We finally obtained 20 key compounds and identified 214 potential targets active against T2DM, among which AKT1, TNF, SRC, VEGFA, EGFR, CASP3, MAPK3, STAT3, PPARG, ESR1, MTOR, PTGS2, and MAPK1 were the key targets. This evidence concerns the gene SRC and type 2 diabetes mellitus.